Literature DB >> 11901505

Wilms tumor gene WT1 as a tumor marker for leukemic blast cells and its role in leukemogenesis.

Haruo Sugiyama1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11901505

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  5 in total

1.  The transcription factor Wilms tumor 1 confers resistance in myeloid leukemia cells against the proapoptotic therapeutic agent TRAIL (tumor necrosis factor α-related apoptosis-inducing ligand) by regulating the antiapoptotic protein Bcl-xL.

Authors:  Hima Bansal; Theresea Seifert; Carlos Bachier; Manjeet Rao; Gail Tomlinson; Swaminathan Padmanabhan Iyer; Sanjay Bansal
Journal:  J Biol Chem       Date:  2012-08-16       Impact factor: 5.157

Review 2.  Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias.

Authors:  A J Barrett; K Rezvani
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

3.  Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.

Authors:  Swati Naik; Spyridoula Vasileiou; Ifigeneia Tzannou; Manik Kuvalekar; Ayumi Watanabe; Catherine Robertson; Natalia Lapteva; Wang Tao; Mengfen Wu; Bambi Grilley; George Carrum; Rammurti T Kamble; LaQuisa Hill; Robert A Krance; Caridad Martinez; Priti Tewari; Bilal Omer; Stephen Gottschalk; Helen E Heslop; Malcom K Brenner; Cliona M Rooney; Juan F Vera; Ann M Leen; Premal D Lulla
Journal:  Blood       Date:  2022-04-28       Impact factor: 25.476

4.  Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

Authors:  Katayoun Rezvani; Agnes S M Yong; Stephan Mielke; Bipin N Savani; Laura Musse; Jeanine Superata; Behnam Jafarpour; Carol Boss; A John Barrett
Journal:  Blood       Date:  2007-09-17       Impact factor: 22.113

5.  Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.

Authors:  Katayoun Rezvani; Agnes S M Yong; Bipin N Savani; Stephan Mielke; Keyvan Keyvanfar; Emma Gostick; David A Price; Daniel C Douek; A John Barrett
Journal:  Blood       Date:  2007-05-15       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.